Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kolmar Korea has extensive commercial manufacturing capabilities (KGMP/PIC/S GMP certified), 17+ active R&D pipeline programs (including new drug and incrementally modified drug candidates mostly in early-stage development for diabetes, hypertension, inflammatory, dermatological, and respiratory indications). Innovative formulation technologies (e.g., Lid-Cap for liquid in hard capsules) are actively in use. No clinical results data are publicly released; drugs are primarily in development up to Phase 3, with a large portfolio of generics, herbal, and OTC products in market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kolmar Korea.